Nintedanib Inhibits Fibroblast Activation and Ameliorates Fibrosis in Preclinical Models of Systemic Sclerosis

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2014-207109

Related search